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THE presence offactors in the blood ofleukaemic patients which influence white
cellproliferation ormaturation wasfirstreportedbyFosterandMiller (1950). These
workers observed changes in the lymph nodes of guinea-pigs following the inocu-
lation of sera from a variety of leukaemic and allied diseases of the reticuloendo-
thelial system.
Similar substances had previously been isolated from the urine of leukaemic
patients (Miller and Turner, 1943; Turner and Miller, 1943).
The presence of myeloid stimulating substances in the urine of leukaemic
patients was confirmed by Hirschmann, Heinle and Wearn, (1945).
Oliva and Tramontana (1950) have reported the presence of similar factors in
the plasma of leukaemic pateints. Temporary elevations in the white counts of
normal persons were observed following the intravenous injection of leukaemic
plasma.
The present experiments were commenced with the aim of cultivating human
leukaemic leucocytes in the brains of very young mice. It was noted that the
inoculation ofsmallvolumesofbloodfrompatients sufferingfromchroniclymphatic
leukaemia resulted in an elevation of the lymphocyte/polymorph ratio in the
circulating blood of these mice. This elevation was at first presumed to be due to
the presence of circulating human lymphocytes.
It was found, however, that a similar elevation ofthe lymphocyte count could
be induced by inoculation of plasma from such patients.
No elevation of either lymphocyte or polymorph levels was produced by the
inoculation of plasma or whole blood from normal persons or persons suffering
from other types ofleukaemia.
MATERIAL AND METHODS
Blood.-Blood was obtained from the following types of case:
Chronic lymphatic leukaemia . . . . . 17 cases.
Acute lymphatic leukaemia . . . . . 5
Chronic myeloid leukaemia . . . . . 8
Acute myeloid leukaemia . . . . . . 8
Multiple myeloma . . . . . . . 3
Normal blood was obtained from members of the Institute staff.
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In each instance 10 ml. of sterile heparinised blood was collected by vene-
puncture. The blood was centrifuged immediately and the supernatant plasma
removed. This plasma was either used immediately or stored at - 150 C. for later
use. No loss of plasma activity was observed following storage at - 150 C. for
several weeks.
Mice.-The mice used were those of the Hall Institute stock. This colony has
been maintained for many years without introduction of new stock, but is by no
means genetically homozygous.
Inoculation of mice.-Each plasma sample was inoculated into three litters of
mice-eighteen mice in all.
Inoculations were made when the mice were 24 hr. of age. The inoculum was
0.01 ml. in volume and was injected in a parasagittal plane midway between the
eye and the ear using a gauge 25 needle.
The mortality from such a procedure was virtually zero.
Blood counts.-Daily total and differential white counts were made on two
mice from each group of eighteen mice. These mice were not used for further
counts. Absolute counts were performed using a modified Levy haemocytometer.
Blood wasobtainedby cuttingoffthe distal centimetre ofthe tailwith a pair of
sharp scissors. The flow of blood resulting was quite free and no manipulation of
the tail was found necessary.
In some experiments coded slides were used to prevent observer error when
making both the absolute and differential counts.
Daily blood counts were performed for seven days and thereafter at weekly
intervals for six weeks.
Histological material.-Material for sectioning was taken at daily intervals
from the livers and spleens ofinoculated animals in a number of the experiments.
Sections ofthe inoculated brains were also made at varying intervals following
inoculation.
The tissues were fixed in Carnoy's fixative, blocked in paraffin, sectioned and
stained with haematoxylin and eosin.
Analysis of results.-An analysis of the results for statistically significant
differences was made using the Student " t " series method.
RESULTS
Normal blood picture in young mice
Atbirth, the predominating white cell in the peripheral blood isthepolymorph.
Between the second and the eighth days the number of lymphocytes in the
blood rises and the number of polymorphs falls. During this period, therefore,
the lymphocyte/polymorph ratio rises progressively to attain the normal adult
ratio of 2-3: 1.
These relationships are illustrated in Fig. 1 and 2.
Blood picture of inoculated mice
Following the inoculation of day-old mice with 0.01 ml. of plasma from cases
of chronic lymphatic leukaemia the circulating lymphocytes increased in number
at agreaterratethaninuninoculated animals. This increase appearedto commence
soon after inoculation, but the rise did not become statistically significant until
the second day following inoculation.
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Fxo. 1.-Normal blood picture of young mice showing progressive daily rise in
lymphocyte: polymorph ratio. Shaded area indicates spread of values obtained.
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FIG. 2.-Normal blood picture of young mice showing progressive daily rise in absolute
lymphocyte counts and fall in polymorph counts.
O O Lymphocytes. *0 - - 0 Polymorphs.
By the sixth post-inoculation day, the relative increase in the number of
circulating lymphocytes reached its maximum point. At this time, the average
lymphocyte: polymorph ratio was 4-5: 1 as compared with the average normal
ratio of 2-5: 1. The absolute number oflymphocytes per cu.mm. in the inoculated
mice at this point was 4000 as opposed to the normal value of 2400 in the uninocu-
lated mice.
These relationships are illustrated in Fig. 3 and 4.
The absolute numbers of polymorphs in both groups was not significantly
different, and the elevation of the lymphocyte/polymorph ratio is clearly due
solely to an increase in the number of circulating lymphocytes.
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FIG. 3.-Rise in lymphocyte: polymorph ratio following intracerebral inoculation of chronic
lymphatic leukaemic plasma. Controls injected with normal plasma. Shaded area
indicates spread of values obtained. Statistical differences indicated.
* 0 Chronic lymphatic leukaemia. 0 O Controls.
Ratio ofincrease = 2-5: 1.
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FIG. 4.-Average rise in absolute lymphocyte count of mice inoculated intracerebrally with
chronic lymphatic leukaemic plasma. Controls injected with normal plasma. Statistical
differences indicated.
0 0 Chronic lymphatic leukaemia. 0 --- 0 Controls.
Ratio of increase = 3: 1.
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After the sixth post-inoculation day the differences between the inoculated and
the normal mice diminished and by the second to third week no differences were
detectable in the blood pictures of the two groups.
The results ofinoculation ofplasma fromnormal persons and cases ofacute and
chronic myeloidleukaemia arerecordedin Fig. 5 and 6. InFig. 7 and 8arerecorded
theresultsfollowing inoculation ofplasma from cases ofacutelymphatic leukaemia
and multiple myeloma.
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FIG. 5.-Average lymphocyte: polymorph ratios of mice inoculated intracerebrally with
acute and chronic myeloid leukaemic plasma. Controls injected with normal plasma.
Statistical differences indicated.
0 O Acute myeloid leukaemia. 0 - -- 0 Chronic myeloid leukaemia.
0 0 Normal mice.
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FIG. 6.-Absolute lymphocyte counts of mice inoculated intracerebrally with acute and
chronic myeloid leukaemic plasma. Controls injected with normal plasma. Statistical
differences indicated.
0 O Acute myeloid leukaemia. 0 - - - 0 Chronic myeloid leukaemia.
* 0 Normal mice.
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In each group no significant differences were found from the results obtained
with normal human plasma. In the experiments with plasma from cases of acute
lymphatic leukaemia and multiple myeloma there was an average rise in the
lymphocyte count which didnotreach thelevel ofsignificance. Onlyfiveandthree
cases, respectively, were available and examination ofalarger series willbe needed
before a decision can be made as to whether a real increase is produced by plasma
from one or both of these conditions.
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FIG. 7.-Average lymphocyte: polymorph ratios of mice inoculated intracerebrally with
acute lymphatic leukaemic and multiple myeloma plasma. Controls injected with normal
plasma. Statistical differences indicated.
0 0 Acute lymphatic leukaemia. 0 - -- 0 Multiple myeloma.
*- Normal mice
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FIG. 8-Absolute lymphocyte counts ofmice inoculated intracerebrally with acute lymphatic
leukaemic and multiple myeloma plasma. Controls injected with normal plasma.Statis.
tical differences indicated.
0 0 O Acute lymphatic leukaemia. 0 - -- 0 Multiple myeloma.
* * Normal mice.
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No evidence was found of an increase in circulating polymorphs in mice
inoculated with myeloid leukaemic plasma.
Of special interest was the finding that the five cases of acute lymphatic
leukaemia gave sharply distinct results from the chronic lymphatic leukaemia
group. This observation is suggestive, but needs amplification using a larger
series.
None ofthe mice in the various inoculated groups showed abnormal circulating
white cells in the peripheral blood at any stage.
None of the inoculated mice developed clinically evident illness during the
observation period of two months following inoculation.
Histological examination of inoculated mice
Foster and Miller (1950) have reported changes in the histology of the lymph
nodes of guinea pigs inoculated with leukaemic plasma.
They described increased lymphopoiesis in the lymph nodes of animals receiv-
ing chronic lymphatic leukaemic plasma. They found a loss oflymphoid structure
and an infiltration of lymph nodes with polymorphs and connective tissue in
animals receiving chronic myeloid leukaemic plasma.
Anexamination ofthelymphnodes oftheinoculatedmice provedimpracticable
because of their small size.
However, serial examinations of the spleens and livers of inoculated and
control mice were carried out at daily intervals.
No differences in the morphology of the spleen were seen between inoculated
and normal groups.
The livers in both groups were intensely infiltrated with haemopoietic tissue
ofbothredandwhite cell series duringthefirstweekfollowing birth. No significant
differences, either in the intensity of this infiltration or in the nature of the cells
involved, could be detected between the two groups.
Examination of the inoculated brains revealed no evidence of local tissue
changes in the nature of localised accumulations of white cells or foci of inflam-
matory reaction.
Correlation of the clinical activity of the disease with the lymphocytosis stimulating
activity of the plasmafrom cases of chronic lymphatic leukaemia
In Table I is presented an analysis ofthe case histories offifteen cases ofchronic
lymphatic leukaemia.
The lymphocytosis stimulating power of the plasma was measured by the
lymphocyte: polymorph ratio on the sixth post-inoculation day.
The clinical activity of the disease was estimated from a consideration of the
following points:
(1) Increasing or decreasing peripheral white count.
(2) Increasing or decreasing level of Rb.
(3) Increase or decrease in size oflymph nodes, spleen and liver.
(4) Duration of the disease.
(5) Length of survival time.
(6) Bone marrow appearances.
The clinical activity was recorded as follows: - remission; 0 condition
stable; + condition increasing in severity.
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TABLE I
White cell Lymphocytosis
Duration count at Clinical stimulating
of time of activity of power (normal
Patient. illness. testing. disease. level 2 4)
BR- . 1 year 8,350 . 2-3
SP . Years . 5,000 . 3- 0
PE . ,, . 3,000 . . 3 8
RO- . 2 years . 51,000 0 . 4-2
RA- . Years . 47,000 . 0 . 4- 3
DE . 6 years . 100,000 . + . 4-6
McG- . 1 year 150,000 . + . 3- 9
NI 1 ,, . 77,000 . + 4- 8
CA- . Years 200,000 . + 3- 2
SP- . 1 year . 47,000 . + 5- 2
HA- . Years . 175,000 . + 4- 5
JA . 1 year . 36,000 . + . 5-
ROU- . Years . 750,000 . + 5-1
STY- . ,, . 34,000 . + 5- 2
FRA- . ,, . 29,000 . + . 4- 6
It may be seen from Table I that there was a fairly good correlation between
theclinical assessment ofthe activityofthedisease andtheobservedlymphocytosis
stimulating activity.
There was only a general correlation between the absolute levels ofwhite cells
in the blood of the patient and plasma activity.
Patient BR-whose plasma lymphocytosis stimulating activity was within
normal limits, had just had a remarkable clinical remission prior to the taking of
his blood for testing. His previous white cell count of 300,000 per c.mm. had
fallen to 8,000 per c.mm., and his general condition had improved considerably
in the week prior to the testing of his plasma.
It is ofinterest to note that patient CA-, whose plasma had a relatively low
lymphocytosis stimulating power, was in an acute terminal phase of the disease.
This is in keeping with the relative lack of plasma activity noted in the five cases
of acute lymphatic leukaemia tested.
DISCUSSION
Control mechanisms responsible for the maintenance of observed levels of
white cells in the circulating blood in health and disease, undoubtedly exist, but
their elucidation has proved difficult.
Foster and Miller (1950) have shown that factors circulate in the plasma of
patients with leukaemic diseases, which stimulate cellular activity in the lymph
nodes of inoculated guinea-pigs. Similar factors in leukaemic plasma have been
shown by Oliva andTramontana (1950)toinfluence the number ofcirculating white
cells in normal human recipients.
The present work has demonstrated the presence of a factor in the plasma of
chronic lymphatic leukaemic patients, which, following intracerebral inoculation,
causes an increase in circulating lymphocytes in baby mice.
There are three possible mechanisms by which the increase in circulating
lymphocytes was produced:
(a) increased production oflymphocytes;
(b) increased release rate of preformed lymphocytes;
(c) increased survival time of circulating lymphocytes.
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The delay, following inoculation, of about two days before a measurable effect
was produced, suggests an increased production of lymphocytes. A time lapse of
only a few hours might be expected if the effect was due to an acceleration of the
release mechanism.
The possibility of an induced prolonged survival time of pre-formed lympho-
cytes is unlikely, but cannot be ignored in view of the evidence of Osgood et al.
(1952) and others of the prolonged survival time of lymphocytes in chronic
lymphatic leukaemia.
Significant elevation ofthe lymphocyte count persisted for a variable period of
six to fourteen days, following a single inoculation. This suggests the activity of
a foreign protein which is being gradually broken down and eliminated.
The time lapse of six days between inoculation of plasma and the production
of the maximum increase in circulating lymphocytes is considerably longer than
the time lag of six hours reported by Oliva and Tramontana (1950) for man. It is
likely that the route of inoculation chosen, the age of the mice, the changing
pattern oftheir haemopoietic tissues and the inherent responsiveness ofthe mouse
as a species, account for these differences.
It is significant that three animal species-the guinea-pig, man and mouse-
have now been shown tobe responsive to the stimuli of circulating factors in the
blood ofleukaemic patients. This increases the likelihood that the experimentally
observed activity of such factors is identical with the natural function of these
factors in the leukaemic patient.
It is doubtful ifthe lymphocytosis stimulating factorin theplasma oflymphatic
leukaemic patients is directly related aetiologically to the disease. However, the
continued presence of such a factor in the plasma ofthese patients must influence
the dynamic equilibrium oflymphocyte production and destruction in the disease.
Along with the known prolonged survival time of the leukaemic lymphocyte
and the evidence of deficient elimination of white cells by the lungs and other
organs of leukaemic patients (Bierman, Kelly and Cordes, 1955), it probably
assists in maintaining thecharacteristically high level of circulating lymphocytes
and the progressive nature of the disease.
It is of interest in this regard that the lymphocytosis-stimulating activity of
the plasma has been found to vary in accordance with the clinical activity of the
disease.
Theexperimentalprocedures described here havenotdemonstrated thepresence
of similar white-cell stimulating factors in other types of leukaemia. This lends
support to the contention of some workers that chronic lymphatic leukaemia
differs fundamentally from other types of leukaemia.
SUMMARY
1. The presence ofa lymphocytosis-stimulating factor in the plasma ofpatients
with chronic lymphatic leukaemia has been demonstrated by the inoculation of
such plasma intracerebrally into baby mice.
2. No lymphocytosis stimulating effect was observed following the inoculation
of normal plasma or plasma from cases of acute and chronic myeloid leukaemia,
acute lymphatic leukaemia and multiple myeloma.
3. The lymphocytosis stimulating activity of the plasma parallels the clinical
activity of the disease.
4. The significance of these findings is discussed.
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